The CPNP Foundation supports the Defining the Future Grant Program designed specifically for students/CPNP student chapters, residents, and fellows interested in psychiatric and neurologic pharmacy. This is an excellent opportunity to receive funding for a research project that will help define the future of neuropsychiatric pharmacy practice and improve the care of patients with psychiatric and neurologic disorders.


To create a competitive selection process challenging students and residents to research innovative and cutting-edge practices that will impact the care of patients into the future, to share this work within the field of pharmacy, and to provide financial support to achieve these outcomes.

Grant Award

Grant applications are accepted annually May-August, and up to three applicants are awarded $1500 each to fund their research project and poster presentation. Depending on the number of suitable applications, not all the grants may be awarded.

2016 Grant Recipients

Andrew Kluemper, PharmD, University of Colorado Health & Anschutz and Lowry Internal Medicine Clinics, will conduct a project entitled “Effect of Primary Care Provider Stigma on Appropriate PHQ-9 Administration.”

The goal of this research is to find out if stigma influences depression management (screening, severity assessment, and treatment) in the primary care setting. To do this, the researcher will 1) Characterize PCP stigma related to depression, and 2) Evaluate the relationship between provider stigma and appropriate Patient Health Questionnaire 9 (PHQ-9) administration.

Jenni-lyn Ladutko, PharmD, Veterans Administration Salt Lake City Healthcare System, will complete her project entitled “Implementation of a PolyphArmacy Clinic in Vulnerable Elders (PAVE Clinic) Within an Integrated Patient Aligned Care Team.”.

The goal of this study is to implement and evaluate the outcomes of a novel, pharmacy run, polypharmacy clinic for patients 75-95 years old within the outpatient Patient Aligned Care Teams (PACT). The purpose of this research is to benefit patient care by giving providers a comprehensive medication review by a pharmacist that assesses medication appropriateness and provides recommendations for overall care.

Samantha Themas, PharmD, Memorial Outpatient Behavioral Health Center, will research “Effect of Clinical Pharmacy Specialist Intervention on Metabolic Markers in Patients Receiving Long-acting Antipsychotic Injections.

The purpose of this study is to assess the impact of a clinical pharmacy specialist-managed long-acting antipsychotic injection clinic on patient outcomes. The goal is to establish a long acting therapy (LAT) clinic in a hospital ambulatory setting that promotes a team-based approach to patient care, comprehensive monitoring of medication side effects and metabolic issues, and improved patient access to expert, integrated care.

Tu Vuong, PharmD student from University of Southern California, will assess “Incorporating Clinical Pharmacy Service into Depression Management at a Primary Care Clinic.

The goal of this study is to incorporate clinical pharmacy services into depression management at a primary care clinic. The researcher will develop a depression care protocol, implement the protocol at the Keck Family Medicine clinic with a supervising pharmacist and physician, conduct a patient/provider/staff satisfaction survey, and analyze the results to evaluate the impact of this program.

2015 Grant Recipient Posters

As a requirement of grant, the four 2015 grant recipients submitted their research for abstract consideration at CPNP 2016. All four were accepted and a PDF of each poster is available to view.

Lauren J. Heath, PharmD: Influence of Patient Stigma on Depression Remission

Carroline P. Lobo, MS: Stigma in Adults with Fibromyalgia Syndrome and Migraine: A Comparative Analysis of Perceptions of Invalidation

Courtney Slough, PharmD: Comprehensive medication management (CMM) provided to veterans in an outpatient traumatic brain injury (TBI) clinic at a Veteran Affairs Medical Center

Natalie Valentino, PharmD: Assessment of Rationale in Refusal of Take-home Naloxone by Veterans at Risk for Opioid Overdose in the Primary Care Setting